Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

Senior Director, Analytical Development CMC

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company · Boston, MA

Posted 29 days ago · $165,000.00 to $250,000.00 · Previously reposted

or apply directly on Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's site. We never take the application ourselves.

Is this posting real?

This role has been open
29 days
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's roles stay open a median of 21 days
Reposted
Yes
taken down and listed again at least once
Salary listed
Yes
90% of Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's roles list one
Ghost-job risk at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company
low
3 stale, 10 reposted of 21 open
Hiring momentum
31 roles opened in the last 90 days
↑ up vs. the prior 90 days
Last confirmed on the employer's board
2026-09-17

Measured from postings appearing on and disappearing from Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's own greenhouse board since 2026-08-03. Full hiring picture for Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company .

About this role

The Senior Director of Analytical Development at Centessa Pharmaceuticals will oversee analytical method development and validation for small molecule drug products, ensuring compliance with cGMP and regulatory guidelines. This role involves collaboration with external CDMOs, leading analytical strategy, and contributing to regulatory submissions while managing analytical data and documentation. The position requires significant experience in the pharmaceutical industry and includes responsibilities such as mentoring junior scientists and participating in cross-functional teams.

Our read on this posting4.4out of 5
benefits
3/5
freshness
4/5
career value
5/5
role clarity
5/5
pay transparency
5/5

Scored from the posting itself — how clearly the role is described, how much it says about pay and benefits, and how recently it was listed. Not a judgement of Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company as an employer.

What you need

  • Advanced degree in chemistry, pharmaceutical sciences, or related field (PhD strongly preferred)
  • 10+ years of small molecule pharmaceutical industry experience
  • Extensive experience in early phase analytical development of small molecule oral solid dosage forms
  • Deep expertise in cGMP and ex-US regulatory requirements for pharmaceutical products
  • Strong technical background in chemical and physical characterization
  • Significant experience in analytical method development and GMP qualification/validation

What you get

  • Annual base salary range of $165,000.00 to $250,000.00
  • Discretionary annual bonus
  • Comprehensive benefits package including 401(k) plan
  • Company-sponsored medical, dental, vision, and life insurance
  • Generous paid time off
  • Health and wellness program

Worth weighing

  • Travel to vendors both domestically and internationally will be required
  • Role involves significant collaboration with third-party vendors
  • Position is full-time and exempt, indicating a potential for a demanding workload

Summarised from Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company 's posting. Read the full original.

Listed by Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company on their greenhouse job board, last confirmed open on 2026-09-17. PitchMeAI is not the employer.

More roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

All 21 open roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

Apply to a Senior Director, Analytical Development CMC position at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company - Jobs near me at Boston, MA